Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03701503
Other study ID # GuthormoneOB-NonOB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2010
Est. completion date July 2011

Study information

Verified date October 2018
Source Indonesia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obesity can occur due to an imbalance of energy. This energy balance is greatly influenced by hunger and satiety. Obese person cannot resist hunger, while non obese can control hunger. Gut hormones, such as PYY and ghrelin, are associated with appetite and satiety control. This study's objective is to compare the effect of breakfast with balance composition on gut hormones, glucose and ad libitum intake four hours after breakfast between obese and non obese..

The research methodology was used a clinical trial with 18 obese women and 22 non obese women participants. Subjects were given a balance breakfast (protein 12,4%, carbohydrate 68,2%, fat 22,6%). Gut hormones (PYY, Ghrelin, GLP -1) level , Glucose level and satiety level were measured at 0, 15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after breakfast and measured after.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 2011
Est. primary completion date July 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- BMI 25 - 30 (for obese am)

- BMI 18,5 - 23 (for NON- obese am)

- with stable body weight within the last 6 months (body weight change less than 4 kg)

- normal blood glucose level.

Exclusion Criteria:

- Patients who never had breakfast

- patients in weight loss program

- patients consuming lipid-absorption inhibitor or appetite-suppressing drugs

- patients that have had gastrointestinal tract resection.

Study Design


Intervention

Behavioral:
Diet with balance composition to know the effect of a meal to gut hormones in obese and non obese women


Locations

Country Name City State
Indonesia Departement of Nutrition, Faculty of Medicine Universitas Indonesia Jakarta Jakarta Pusat

Sponsors (3)

Lead Sponsor Collaborator
Indonesia University Dr Cipto Mangunkusumo General Hospital, SEAMEO Regional Centre for Food and Nutrition

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ghrelin levels at 0 minute analyzed by ELISA, directly taken after having the breakfast with balance composition in both of the study arm. baseline
Primary Ghrelin levels at 15 minute analyzed by ELISA, taken 15 minutes after having the breakfast with balance composition in both of the study arm. 15 minutes
Primary Ghrelin levels at 60 minute analyzed by ELISA, taken 60 minutes after having the breakfast with balance composition in both of the study arm. 60 minutes
Primary Ghrelin levels at 120 minute analyzed by ELISA, taken 120 minutes after having the breakfast with balance composition in both of the study arm 120 minutes
Primary Ghrelin levels at 180 minute analyzed by ELISA, taken 180 minutes after having the breakfast with balance composition in both of the study arm 180 minutes
Primary PYY levels at 0 minute analyzed by Radioimmunoassay, directly taken after having the breakfast with balance composition in both of the study arm baseline
Primary PYY levels at 15 minute analyzed by Radioimmunoassay, taken 15 minutes after having the breakfast with balance composition in both of the study arm 15 minutes
Primary PYY levels at 60 minute analyzed by Radioimmunoassay, taken 60 minutes after having the breakfast with balance composition in both of the study arm 60 minutes
Primary PYY levels at 120 minute analyzed by Radioimmunoassay, taken 120 minutes after having the breakfast with balance composition in both of the study arm 120 minutes
Primary PYY levels at 180 minute analyzed by Radioimmunoassay, taken 180 minutes after having the breakfast with balance composition in both of the study arm 180 minutes
Primary GLP-1 levels at 0 minute analyzed by ELISA, directly taken after having the breakfast with balance composition in both of the study arm baseline
Primary GLP-1 levels at 15 minute analyzed by ELISA, taken 15 minutes after having the breakfast with balance composition in both of the study arm 15 minutes
Primary GLP-1 levels at 60 minute analyzed by ELISA, taken 60 minutes after having the breakfast with balance composition in both of the study arm 60 minutes
Primary GLP-1 levels at 120 minute analyzed by ELISA, taken 120 minutes after having the breakfast with balance composition in both of the study arm 120 minutes
Primary GLP-1 levels at 180 minute analyzed by ELISA, taken 180 minutes after having the breakfast with balance composition in both of the study arm 180 minutes
Primary Glucose levels at 0 minute analyzed by standard random glucose level from venous blood, directly taken after having the breakfast with balanced composition in both of the study arm baseline
Primary Glucose levels at 15 minute analyzed by standard random glucose level from venous blood, taken 15 minutes after having the breakfast with balanced composition in both of the study arm 15 minutes
Primary Glucose levels at 60 minute analyzed by standard random glucose level from venous blood, taken 60 minutes after having the breakfast with balanced composition in both of the study arm 60 minutes
Primary Glucose levels at 120 minute analyzed by standard random glucose level from venous blood, taken 120 minutes after having the breakfast with balanced composition in both of the study arm 120 minutes
Primary Glucose levels at 180 minute analyzed by standard random glucose level from venous blood, taken 180 minutes after having the breakfast with balanced composition in both of the study arm 180 minutes
Primary Ad Libitum intake Mean Ad Libitum intake (calories) in subjects four hours after breakfast with balance composition in both of the study arm 4 hours
Primary VAS for hunger at 0 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), directly taken after having the breakfast with balance composition in both of the study arm baseline
Primary VAS for hunger at 15 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with balance composition in both of the study arm 15 minutes
Primary VAS for hunger at 60 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with balance composition in both of the study arm 60 minutes
Primary VAS for hunger at 120 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with balance composition in both of the study arm 120 minutes
Primary VAS for hunger at 180 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with balance composition in both of the study arm 180 minutes
Primary VAS for satiety at 0 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), directly taken after having the breakfast with balance composition in both of the study arm baseline
Primary VAS for satiety at 15 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with balance composition in both of the study arm 15 minutes
Primary VAS for satiety at 60 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with balance composition in both of the study arm 60 minutes
Primary VAS for satiety at 120 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with balance composition in both of the study arm 120 minutes
Primary VAS for satiety at 180 minutes Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with balance composition in both of the study arm 180 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2